Neurocognitive Function After (Chemo)-Radiotherapy for Head and Neck Cancer

Clinical Oncology

Volumn 26, Issue 12, 2014, Pages 765-775

  Welsh, L C ^a,b   Dunlop, A W ^b   McGovern, T ^b   McQuaid, D ^b   Dean, J A ^a   Gulliford, S L ^a   Bhide, S A ^a,b   Harrington, K J ^a,b   Nutting, C M ^b   Newbold, K L ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Head and neck cancer; Neurocognitive impairment; Radiotherapy

Indexed keywords

ARTICLE; BRAIN INJURY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; COGNITION; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; NASOPHARYNX CARCINOMA; NEUROTOXICITY; TEMPORAL LOBE; CHEMICALLY INDUCED; COGNITION DISORDERS; COHORT ANALYSIS; HEAD AND NECK NEOPLASMS; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; RADIATION INJURIES;

CHEMORADIOTHERAPY; COGNITION DISORDERS; COHORT STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; NEUROPSYCHOLOGICAL TESTS; RADIATION INJURIES; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84911958883     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2014.06.014     Document Type: Article

References (100)

1. Corvò R. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiother Oncol 2007, 85:156-170.
2. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
3. Joseph A.W., D'Souza G. Epidemiology of human papillomavirus-related head and neck cancer. Otolaryngol Clin North Am 2012, 45:739-764.
4. Curado M.P., Boyle P. Epidemiology of head and neck squamous cell carcinoma not related to tobacco or alcohol. Curr Opin Oncol 2013, 25:229-234.
5. Mehanna H., Beech T., Nicholson T., et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer - systematic review and meta-analysis of trends by time and region. Head Neck 2013, 35:747-755.
6. Panwar A., Batra R., Lydiatt W.M., Ganti A.K. Human papilloma virus positive oropharyngeal squamous cell carcinoma: a growing epidemic. Cancer Treat Rev 2014, 40:215-219.
7. Lefebvre J.L. Surgery for laryngopharyngeal SCC in the era of organ preservation. Clin Exp Otorhinolaryngol 2009, 2:159-163.
8. de Bree R., Leemans C.R. Recent advances in surgery for head and neck cancer. Curr Opin Oncol 2010, 22:186-193.
9. Dirix P., Nuyts S. Evidence-based organ-sparing radiotherapy in head and neck cancer. Lancet Oncol 2010, 11:85-91.
10. Mehanna H., West C.M.L., Nutting C., Paleri V. Head and neck cancer - Part 2: treatment and prognostic factors. Br Med J 2010, 341:c4690.
11. Bhide S.A., Newbold K.L., Harrington K.J., Nutting C.M. Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers. Br J Radiol 2012, 85:487-494.
12. Gulliford S.L., Miah A.B., Brennan S., et al. Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT phase III trial. Radiother Oncol 2012, 104:205-212.
13. Powell C., Schick U., Morden J.P., et al. Fatigue during chemoradiotherapy for nasopharyngeal cancer and its relationship to radiation dose distribution in the brain. Radiother Oncol 2014, 110:416-421.
14. Lorenzo N.D., Nolletti A., Palma L. Late cerebral radionecrosis. Surg Neurol 1978, 10:281-290.
15. Glass J.P., Hwang T.L., Leavens M.E., Libshitz H.I. Cerebral radiation necrosis following treatment of extracranial malignancies. Cancer 1984, 54:1966-1972.
16. Abayomi O.K. Pathogenesis of cognitive decline following therapeutic irradiation for head and neck tumors. Acta Oncol 2002, 41:346-351.
17. Ang K.K.K.K., Garden A.S. Radiotherapy for head and neck cancers: indications and techniques 2006, Lippincott Williams & Wilkins, Philadelphia.
18. Lawrence Y.R., Li X.A., Naqa El I., et al. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 2010, 76:S20-S27.
19. Mayo C., Yorke E., Merchant T.E. Radiation associated brainstem injury. Int J Radiat Oncol Biol Phys 2010, 76:S36-S41.
20. Roman D.D., Sperduto P.W. Neuropsychological effects of cranial radiation: current knowledge and future directions. Int J Radiat Oncol Biol Phys 1995, 31:983-998.
21. Abayomi O.K. Pathogenesis of irradiation-induced cognitive dysfunction. Acta Oncol 1996, 35:659-663.
22. Soussain C., Ricard D., Fike J.R., Mazeron J.-J., Psimaras D., Delattre J.-Y. CNS complications of radiotherapy and chemotherapy. Lancet 2009, 374:1639-1651.
23. Greene-Schloesser D., Robbins M.E., Peiffer A.M., Shaw E.G., Wheeler K.T., Chan M.D. Radiation-induced brain injury: a review. Front Oncol 2012, 2:73.
24. Lee P.W., Hung B.K., Woo E.K., Tai P.T., Choi D.T. Effects of radiation therapy on neuropsychological functioning in patients with nasopharyngeal carcinoma. JNeurol Neurosurg Psychiatr 1989, 52:488-492.
25. Nutting C.M., Morden J.P., Harrington K.J., et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011, 12:127-136.
26. Cabrera A.R., Yoo D.S., Brizel D.M. Contemporary radiotherapy in head and neck cancer: balancing chance for cure with risk for complication. Surg Oncol Clin N Am 2013, 22:579-598.
27. Followill D., Geis P., Boyer A. Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy. Int J Radiat Oncol Biol Phys 1997, 38:667-672.
28. Hall E.J., Wuu C.-S. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003, 56:83-88.
29. Hall E.J. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 2006, 65:1-7.
30. Smith D.M., Atkinson R.M. Alcoholism and dementia. Int J Addict 1995, 30:1843-1869.
31. Anstey K.J., Mack H.A., Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry 2009, 17:542-555.
32. Vetreno R.P., Hall J.M., Savage L.M. Alcohol-related amnesia and dementia: animal models have revealed the contributions of different etiological factors on neuropathology, neurochemical dysfunction and cognitive impairment. Neurobiol Learn Mem 2011, 96:596-608.
33. Caracciolo B., Xu W., Collins S., Fratiglioni L. Cognitive decline, dietary factors and gut-brain interactions. Mech Ageing Dev 2014, 136-137:59-69.
34. Morley J.E. Cognition and nutrition. Curr Opin Clin Nutr Metab Care 2014, 17:1-4.
35. Anstey K.J., Sanden von C., Salim A., O'Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 2007, 166:367-378.
36. Peters R., Poulter R., Warner J., Beckett N., Burch L., Bulpitt C. Smoking, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatr 2008, 8:36.
37. Chamberlain S.R., Odlaug B.L., Schreiber L.R.N., Grant J.E. Association between tobacco smoking and cognitive functioning in young adults. Am J Addict 2012, 21(Suppl. 1):S14-S19.
38. Deprez S., Amant F., Smeets A., et al. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. JClin Oncol 2012, 30:274-281.
39. Hodgson K.D., Hutchinson A.D., Wilson C.J., Nettelbeck T. Ameta-analysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treat Rev 2013, 39:297-304.
40. Tang Y., Luo D., Rong X., Shi X., Peng Y. Psychological disorders, cognitive dysfunction and quality of life in nasopharyngeal carcinoma patients with radiation-induced brain injury. PLoS ONE 2012, 7:e36529.
41. Gan H.K., Bernstein L.J., Brown J., et al. Cognitive functioning after radiotherapy or chemoradiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2011, 81:126-134.
42. Hsiao K.-Y., Yeh S.-A., Chang C.-C., Tsai P.-C., Wu J.-M., Gau J.-S. Cognitive function before and after intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: a prospective study. Int J Radiat Oncol Biol Phys 2010, 77:722-726.
43. Yuen H.K., Sharma A.K., Logan W.C., Gillespie M.B., Day T.A., Brooks J.O. Radiation dose, driving performance, and cognitive function in patients with head and neck cancer. Radiother Oncol 2008, 87:304-307.
44. Cheung M.-C., Chan A.S., Law S.C., Chan J.H., Tse V.K. Impact of radionecrosis on cognitive dysfunction in patients after radiotherapy for nasopharyngeal carcinoma. Cancer 2003, 97:2019-2026.
45. Lam L.C.W., Leung S.F., Chan Y.L. Progress of memory function after radiation therapy in patients with nasopharyngeal carcinoma. JNeuropsychiatry Clin Neurosci 2003, 15:90-97.
46. Cheung M., Chan A.S., Law S.C., Chan J.H., Tse V.K. Cognitive function of patients with nasopharyngeal carcinoma with and without temporal lobe radionecrosis. Arch Neurol 2000, 57:1347-1352.
47. Meyers C.A., Geara F., Wong P.F., Morrison W.H. Neurocognitive effects of therapeutic irradiation for base of skull tumors. Int J Radiat Oncol Biol Phys 2000, 46:51-55.
48. Hua M.S., Chen S.T., Tang L.M., Leung W.M. Neuropsychological function in patients with nasopharyngeal carcinoma after radiotherapy. JClin Exp Neuropsychol 1998, 20:684-693.
49. Glosser G., McManus P., Munzenrider J. Neuropsychological function in adults after high dose fractionated radiation therapy of skull base tumors. Int J Radiat Oncol Biol Phys 1997, 38:231-239.
50. Squire L.R., Wixted J.T. The cognitive neuroscience of human memory since H.M. Annu Rev Neurosci 2011, 34:259-288.
51. Wixted J.T., Squire L.R. The medial temporal lobe and the attributes of memory. Trends Cogn Sci (Regul Ed) 2011, 15:210-217.
52. Yuen H.K., Gillespie M.B., Barkley R.A., Day T.A., Bandyopadhyay D., Sharma A.K. Driving performance in patients with cancer in the head and neck region: a pilot study. Arch Otolaryngol Head Neck Surg 2007, 133:904-909.
53. Yuen H.K., Gillespie M.B., Day T.A., Morgan L., Burik J.K. Driving behaviors in patients with head and neck cancer during and after cancer treatment: a preliminary report. Head Neck 2007, 29:675-681.
54. Brunner V., Houyau P., Chatelut E., Roché H., Canal P. Cerebrospinal fluid concentrations of carboplatin in a patient without blood-brain barrier disruption. Cancer Chemother Pharmacol 1995, 35:352-353.
55. Jacobs S.S., Fox E., Dennie C., Morgan L.B., McCully C.L., Balis F.M. Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates. Clin Cancer Res 2005, 11:1669-1674.
56. Jacobs S., McCully C.L., Murphy R.F., Bacher J., Balis F.M., Fox E. Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates. Cancer Chemother Pharmacol 2010, 65:817-824.
57. Dietrich J., Han R., Yang Y., Mayer-Pröschel M., Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents invitro and invivo. JBiol 2006, 5:22.
58. Ljubimova N.V., Levitman M.K., Plotnikova E.D., Eidus L.K. Endothelial cell population dynamics in rat brain after local irradiation. Br J Radiol 1991, 64:934-940.
59. Peña L.A., Fuks Z., Kolesnick R.N. Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency. Cancer Res 2000, 60:321-327.
60. Li Y.-Q., Chen P., Haimovitz-Friedman A., Reilly R.M., Wong C.S. Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing radiation. Cancer Res 2003, 63:5950-5956.
61. Cao Y., Tsien C.I., Sundgren P.C., et al. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for prediction of radiation-induced neurocognitive dysfunction. Clin Cancer Res 2009, 15:1747-1754.
62. Jonson R., Börjesson J., Mattsson S., Unsgaard B., Wallgren A. Uptake and retention of platinum in patients undergoing cisplatin therapy. Acta Oncol 1991, 30:315-319.
63. McCaffrey J.C., Weitzner M., Kamboukas D., Haselhuhn G., Lamonde L., Booth-Jones M. Alcoholism, depression, and abnormal cognition in head and neck cancer: a pilot study. Otolaryngol Head Neck Surg 2007, 136:92-97.
64. Bond S.M., Dietrich M.S., Murphy B.A. Neurocognitive function in head and neck cancer patients prior to treatment. Support Care Cancer 2012, 20:149-157.
65. Gondi V., Tome W.A., Mehta M.P. Why avoid the hippocampus? A comprehensive review. Radiother Oncol 2010, 97:370-376.
66. Rogers L.Q., Courneya K.S., Robbins K.T., et al. Factors associated with fatigue, sleep, and cognitive function among patients with head and neck cancer. Head Neck 2008, 30:1310-1317.
67. McClintock S.M., Husain M.M., Greer T.L., Cullum C.M. Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis. Neuropsychology 2010, 24:9-34.
68. Mesholam-Gately R.I., Giuliano A.J., Zillmer E.A., et al. Verbal learning and memory in older adults with minor and major depression. Arch Clin Neuropsychol 2012, 27:196-207.
69. Sarapas C., Shankman S.A., Harrow M., Goldberg J.F. Parsing trait and state effects of depression severity on neurocognition: evidence from a 26-year longitudinal study. JAbnorm Psychol 2012, 121:830-837.
70. Snyder H.R. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. Psychol Bull 2013, 139:81-132.
71. Kugaya A., Akechi T., Okuyama T., et al. Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer 2000, 88:2817-2823.
72. Katz M.R., Kopek N., Waldron J., Devins G.M., Tomlinson G. Screening for depression in head and neck cancer. Psychooncology 2004, 13:269-280.
73. Chen A.M., Jennelle R.L.S., Grady V., et al. Prospective study of psychosocial distress among patients undergoing radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2009, 73:187-193.
74. Monje M. Cranial radiation therapy and damage to hippocampal neurogenesis. Dev Disabil Res Rev 2008, 14:238-242.
75. Greene-Schloesser D., Moore E., Robbins M.E. Molecular pathways: radiation-induced cognitive impairment. Clin Cancer Res 2013, 19:2294-2300.
76. Lee A.W., Foo W., Chappell R., et al. Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1998, 40:35-42.
77. Gondi V., Hermann B.P., Mehta M.P., Tome W.A. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors. Int J Radiat Oncol Biol Phys 2013, 85:348-354.
78. Walsh T.J., Clark A.W., Parhad I.M., Green W.R. Neurotoxic effects of cisplatin therapy. Arch Neurol 1982, 39:719-720.
79. Namikawa K., Asakura M., Minami T., Okazaki Y., Kadota E., Hashimoto S. Toxicity of cisplatin to the central nervous system of male rabbits. Biol Trace Elem Res 2000, 74:223-235.
80. Troy L., McFarland K., Littman-Power S., et al. Cisplatin-based therapy: a neurological and neuropsychological review. Psychooncology 2000, 9:29-39.
81. Han R., Yang Y.M., Dietrich J., Luebke A., Mayer-Pröschel M., Noble M. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. JBiol 2008, 7:12.
82. Mustafa S., Walker A., Bennett G., Wigmore P.M. 5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus. Eur J Neurosci 2008, 28:323-330.
83. ElBeltagy M., Mustafa S., Umka J., et al. The effect of 5-fluorouracil on the long term survival and proliferation of cells in the rat hippocampus. Brain Res Bull 2012, 88:514-518.
84. Peiffer A.M., Leyrer C.M., Greene-Schloesser D.M., et al. Neuroanatomical target theory as a predictive model for radiation-induced cognitive decline. Neurology 2013, 80:747-753.
85. Acharya M.M., Christie L.-A., Lan M.L., et al. Rescue of radiation-induced cognitive impairment through cranial transplantation of human embryonic stem cells. Proc Natl Acad Sci USA 2009, 106:19150-19155.
86. Acharya M.M., Christie L.-A., Lan M.L., et al. Human neural stem cell transplantation ameliorates radiation-induced cognitive dysfunction. Cancer Res 2011, 71:4834-4845.
87. Joo K.M., Jin J., Kang B.G., et al. Trans-differentiation of neural stem cells: a therapeutic mechanism against the radiation induced brain damage. PLoS ONE 2012, 7:e25936.
88. Monje M.L., Toda H., Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003, 302:1760-1765.
89. Zhao W., Payne V., Tommasi E., Diz D.I., Hsu F.-C., Robbins M.E. Administration of the peroxisomal proliferator-activated receptor gamma agonist pioglitazone during fractionated brain irradiation prevents radiation-induced cognitive impairment. Int J Radiat Oncol Biol Phys 2007, 67:6-9.
90. Ramanan S., Kooshki M., Zhao W., Hsu F.-C., Riddle D.R., Robbins M.E. The PPARalpha agonist fenofibrate preserves hippocampal neurogenesis and inhibits microglial activation after whole-brain irradiation. Int J Radiat Oncol Biol Phys 2009, 75:870-877.
91. Robbins M.E., Payne V., Tommasi E., et al. The AT1 receptor antagonist, L-158,809, prevents or ameliorates fractionated whole-brain irradiation-induced cognitive impairment. Int J Radiat Oncol Biol Phys 2009, 73:499-505.
92. Robbins M.E., Zhao W., Garcia-Espinosa M.A., Diz D.I. Renin-angiotensin system blockers and modulation of radiation-induced brain injury. Curr Drug Targets 2010, 11:1413-1422.
93. Lee T.C., Greene-Schloesser D., Payne V., et al. Chronic administration of the angiotensin-converting enzyme inhibitor, ramipril, prevents fractionated whole-brain irradiation-induced perirhinal cortex-dependent cognitive impairment. Radiat Res 2012, 178:46-56.
94. Gondi V., Mehta M.P., Pugh S., et al. Memory preservation with conformal avoidance of the hippocampus during whole-brain radiation therapy for patients with brain metastases: primary endpoint results of RTOG 0933. Int J Radiat Oncol Biol Phys 2013, 87:1186.
95. Monje M.L., Mizumatsu S., Fike J.R., Palmer T.D. Irradiation induces neural precursor-cell dysfunction. Nat Med 2002, 8:955-962.
96. Mizumatsu S., Monje M.L., Morhardt D.R., Rola R., Palmer T.D., Fike J.R. Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res 2003, 63:4021-4027.
97. Monje M., Thomason M.E., Rigolo L., et al. Functional and structural differences in the hippocampus associated with memory deficits in adult survivors of acute lymphoblastic leukemia. Pediatr Blood Cancer 2013, 60:293-300.
98. Chapman C.H., Nazem-Zadeh M., Lee O.E., et al. Regional variation in brain white matter diffusion index changes following chemoradiotherapy: a prospective study using tract-based spatial statistics. PLoS ONE 2013, 8:e57768.
99. Gulliford S., Miah A., Brennan S., Partridge M., Harrington K., Nutting C. The dose-volume response of posterior fossa and brainstem with respect to acute fatigue. Radiother Oncol 2011, 99(Suppl.):S428.
100. Halperin E.C. Randomized prospective trials of innovative radiotherapy technology are necessary. JAm Coll Radiol 2009, 6:33-37.